IP Verse

Ovid Therapeutics Inc. vs Marinus Pharmaceuticals, Inc.

The detailed information for PTAB case with proceeding number IPR2024-00726 filed by Ovid Therapeutics Inc. against Marinus Pharmaceuticals, Inc. on Mar 26, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2024-00726
Filing Date: Mar 26, 2024
Petitioner: Ovid Therapeutics Inc.
Respondent: Marinus Pharmaceuticals, Inc.
Status: Institution Denied
Respondent Application Number: 17186569
Respondent Tech Center: 1600
Respondent Patent Number: 11110100
Institution Decision Date: Sep 20, 2024
Termination Date: Sep 20, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice: refund approved	Oct 9, 2024	PAPER	BOARD
Petitioner's Request for Refund of Post-Institution Fees	Oct 3, 2024	PAPER	PETITIONER
Denying Institution of Inter Partes Review 35 U.S.C. § 314	Sep 20, 2024	PAPER	BOARD
Patent Owner's Preliminary Response	Jun 26, 2024	PAPER	PATENT OWNER
Declaration of Dr. Maciej Gasior	Jun 26, 2024	EXHIBIT	PATENT OWNER
Declaration of Dr. Henrikas Vaitkevicius	Jun 26, 2024	EXHIBIT	PATENT OWNER
Abstracts for the 17th Annual Meeting, Neurocritical Care Society	Jun 26, 2024	EXHIBIT	PATENT OWNER
Marinus Press Release Dated October 17, 2019	Jun 26, 2024	EXHIBIT	PATENT OWNER
Marinus Press Release dated December 7, 2019	Jun 26, 2024	EXHIBIT	PATENT OWNER
American Clinical Neurophysiology Society 2020 Annual Meeting	Jun 26, 2024	EXHIBIT	PATENT OWNER
Marinus Press Release dated February 3, 2020	Jun 26, 2024	EXHIBIT	PATENT OWNER
Declaration of Anne Koch Baland with Attachments	Jun 26, 2024	EXHIBIT	PATENT OWNER
Declaration of Dr. Michael A. Rogawski	Jun 26, 2024	EXHIBIT	PATENT OWNER
WO 2016/127170A1 Zhang	Jun 26, 2024	EXHIBIT	PATENT OWNER
WO 2018/031748A1 During PCT	Jun 26, 2024	EXHIBIT	PATENT OWNER
Supplemental Response filed May 11, 2022	Jun 26, 2024	EXHIBIT	PATENT OWNER
Petition for Post Grant Review of U.S. Patent No. 11,395,817	Jun 26, 2024	EXHIBIT	PATENT OWNER
U.S. Provisional Patent Application 62/882,648	Jun 26, 2024	EXHIBIT	PATENT OWNER
U.S. Application No. 2016/0228454 Zhang US	Jun 26, 2024	EXHIBIT	PATENT OWNER
Declaration of Raman Sankar, M.D	Jun 26, 2024	EXHIBIT	PATENT OWNER
https://ovidrx.com/our-company/leadership/, accessed June 20, 2024	Jun 26, 2024	EXHIBIT	PATENT OWNER
Reddy and Kuruba, Experimental Models of Status Epilepticus and Neuronal Injury for Evaluation of Therapeutic Interventions	Jun 26, 2024	EXHIBIT	PATENT OWNER
Seinfeld et al., Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Imtiyaz et al., The Evolution of the Pilocarpine Animal Model of Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Press Release Marinus Pharmaceuticals Doses First Subject in Phase I Clinical Trial for Ganaxolone IV	Jun 26, 2024	EXHIBIT	PATENT OWNER
Press Release Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone IV to Treat Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
WIPO Publication No. WO 2007/062266 Shaw	Jun 26, 2024	EXHIBIT	PATENT OWNER
American Academy of Neurology (“AAN”) 2016 Annual Meeting Scientific Abstract	Jun 26, 2024	EXHIBIT	PATENT OWNER
Saporito et al., Ganaxolone Administered Intravenously Prevents Behavioral Seizures and Promotes Survival in the Rat Lithium-Pilocarpine Model of Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Saporito et al., Intravenous Administration of Ganaxolone Attenuates Electroencephalographic Seizures in a Diazepam Resistant Model of Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Tsai et al., Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults	Jun 26, 2024	EXHIBIT	PATENT OWNER
Supplemental Information to Vaitkevicius et al., Intravenous Ganaxolone for the Treatment of Refractory Status Epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Wylie et al., Status Epilepticus. Updated 2022 May 15	Jun 26, 2024	EXHIBIT	PATENT OWNER
Trinka et al., A definition and classification of status epilepticus	Jun 26, 2024	EXHIBIT	PATENT OWNER
Transcript of Deposition of Dr. Raman Sankar, February 9, 2024	Jun 26, 2024	EXHIBIT	PATENT OWNER
Notice: Notice filing date accorded	Apr 11, 2024	PAPER	BOARD
Patent Owner's Mandatory Notice	Apr 4, 2024	PAPER	PATENT OWNER
Patent Owner's Power of Attorney	Apr 4, 2024	PAPER	PATENT OWNER
US 11,110,100	Mar 26, 2024	EXHIBIT	PETITIONER
During	Mar 26, 2024	EXHIBIT	PETITIONER
Tsai 2017	Mar 26, 2024	EXHIBIT	PETITIONER
Tsai 2016	Mar 26, 2024	EXHIBIT	PETITIONER
Ramsay 2019	Mar 26, 2024	EXHIBIT	PETITIONER
Husain 2020	Mar 26, 2024	EXHIBIT	PETITIONER
AES Poster 2019	Mar 26, 2024	EXHIBIT	PETITIONER
Reddy	Mar 26, 2024	EXHIBIT	PETITIONER
June 2023 Marinus Corporate Presentation	Mar 26, 2024	EXHIBIT	PETITIONER
Trinka	Mar 26, 2024	EXHIBIT	PETITIONER
Vaitkevicius 2022	Mar 26, 2024	EXHIBIT	PETITIONER
Hixson 2010	Mar 26, 2024	EXHIBIT	PETITIONER
Shorvon 2001	Mar 26, 2024	EXHIBIT	PETITIONER
Ozdemir 2005	Mar 26, 2024	EXHIBIT	PETITIONER
Monaghan 1997	Mar 26, 2024	EXHIBIT	PETITIONER
Carter 1997	Mar 26, 2024	EXHIBIT	PETITIONER
Shaw	Mar 26, 2024	EXHIBIT	PETITIONER
Sperling 2017	Mar 26, 2024	EXHIBIT	PETITIONER
2016 Phase 1 Poster	Mar 26, 2024	EXHIBIT	PETITIONER
Broomall 2014	Mar 26, 2024	EXHIBIT	PETITIONER
Zolkowska 2018	Mar 26, 2024	EXHIBIT	PETITIONER
Vaitkevicius 2017	Mar 26, 2024	EXHIBIT	PETITIONER
'100 patent FH_excerpted	Mar 26, 2024	EXHIBIT	PETITIONER
Sankar 2023	Mar 26, 2024	EXHIBIT	PETITIONER
'648 application	Mar 26, 2024	EXHIBIT	PETITIONER
WO '124 A1	Mar 26, 2024	EXHIBIT	PETITIONER
Currie 2018	Mar 26, 2024	EXHIBIT	PETITIONER
Excerpts from File History of App. No. 15/673,737	Mar 26, 2024	EXHIBIT	PETITIONER
Sankar Declaration	Mar 26, 2024	EXHIBIT	PETITIONER
NCT03350035 Clinical Trial	Mar 26, 2024	EXHIBIT	PETITIONER
Clinical Leader Press Release	Mar 26, 2024	EXHIBIT	PETITIONER
Practical Neurology 2019	Mar 26, 2024	EXHIBIT	PETITIONER
Marinus's Orphan Drug Press Release	Mar 26, 2024	EXHIBIT	PETITIONER
Marinus's Phase 1 Press Release	Mar 26, 2024	EXHIBIT	PETITIONER
May 18, 2015 Marinus Press Release	Mar 26, 2024	EXHIBIT	PETITIONER
Annals of Neurology Screenshot	Mar 26, 2024	EXHIBIT	PETITIONER
Petition for an Inter Partes Review of U.S. Patent No. 11,110,100	Mar 26, 2024	PAPER	PETITIONER
Petitioner's Power of Attorney	Mar 26, 2024	PAPER	PETITIONER